Life Science News

RSS

Scientists develop new technique to study sugars on immune cells

Everyone loves a sweet treat, even our cells. While we typically think of sugar as a component of our diet that gives us energy, sugars are also very important in guiding the activity of our cells.

5 Sep 2023

Gut feeling: How your microbiome could be shaping your mental health

Researchers in Biological Psychiatry delve into the complex relationship between the gut microbiome and mental health disorders like depression and bipolar disorder. The study explores how not just gut bacteria, but also lesser-known gut microorganisms such as viruses, fungi, and parasites, play a pivotal role in mood disorders.

5 Sep 2023

Rotating shoulders and extending elbows may have evolved as a natural braking system for primates

The rotating shoulders and extending elbows that allow humans to reach for a high shelf or toss a ball with friends may have first evolved as a natural braking system for our primate ancestors who simply needed to get out of trees without dying.

5 Sep 2023

Illumina's board appoints Jacob Thaysen, Ph.D. as its new Chief Executive Officer

llumina today announced that its Board of Directors has appointed Jacob Thaysen, Ph.D., as Chief Executive Officer, effective September 25, 2023.

From Illumina, Inc. 5 Sep 2023

Mutational changes in Avian flu virus could increase risk of transmission to humans

A new study from researchers in China and Nottingham has discovered that a subtype of avian flu virus, endemic in poultry farms in China, is undergoing mutational changes, which could increase the risk of the disease being passed on to humans.

5 Sep 2023

NGS-based screening identifies rare and novel thalassemia mutations in Ganzhou, China

Around 5.2% of the global population carries abnormal hemoglobin genes. Each year, 300,000 to 500,000 children are born with severe hemoglobinopathies worldwide, with approximately 80% of these cases occurring in developing countries.

5 Sep 2023

New blood test pinpoints Parkinson's disease through mitochondrial DNA damage

Researchers have developed a new blood test that measures mitochondrial DNA damage as a potential marker for Parkinson's disease (PD). The study shows the test could aid in diagnosing PD and assessing responses to LRRK2 kinase inhibitors, which may help in reducing mitochondrial damage in PD patients.

4 Sep 2023

Silencing two genes can make cancer cells receptive to chemotherapy

Scientists from Queen Mary University of London have discovered two new genes that cause head and neck cancer patients to be resistant to chemotherapy, and that silencing either gene can make cancer cells previously unresponsive to chemotherapy subsequently respond to it.

4 Sep 2023

Some communities express mistrust and cynicism in response to conversations about genomics

New research published today in Human Genetics and Genomics Advances reveals the difference between ‘what we say’ and ‘what people hear’ when engaging underrepresented communities around genomics and healthcare.

4 Sep 2023

Innovate UK funding to support the development of powdered gene therapy for bone graft augmentation

TherageniX, a University of Nottingham spin out pioneering a dry powder gene therapy formulation for bone graft augmentation, and its collaborator, the University of Nottingham, have been awarded a £995,000 grant from Innovate UK, the UK’s innovation agency.

4 Sep 2023

Study sheds light on immune cells' ability to collectively migrate through complex environments

When fighting disease, our immune cells need to reach their target quickly. Researchers at the Institute of Science and Technology Austria (ISTA) now discovered that immune cells actively generate their own guidance system to navigate through complex environments.

1 Sep 2023

Explosive Hazard Identification in Pharmaceutical Process Development

Scitegrity, a leading company in chemical regulatory compliance, is excited to announce the expanded release of its Dangerous Goods Assessor for Pharmaceutical Process Development and safety teams.

From Scitegrity 1 Sep 2023

Amgen presents late-breaking Phase 2 olpasiran data at ESC 2023

Amgen today announced data from the final analysis of the Phase 2 OCEAN(a)-DOSE study of olpasiran, a small interfering RNA (siRNA) during the Late-Breaking Science Session at the European Society of Cardiology (ESC) Annual Meeting being held in Amsterdam. In the off-treatment extension period, olpasiran showed a lasting effect on Lp(a) reduction nearly a year after the last dose.

From AMGEN 1 Sep 2023

Amgen to discuss application for LUMAKRAS® (sotorasib) for the treatment of KRAS G12C-positive NSCLC at FDA advisory committee meeting

Amgen today announced the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) will review data supporting the supplemental New Drug Application (sNDA) for the full approval of LUMAKRAS® (sotorasib) for adults with previously treated locally advanced or metastatic KRAS G12C-mutated non-small cell lung cancer (NSCLC) at a meeting on Oct. 5, 2023.

From AMGEN 1 Sep 2023

Ancient population bottleneck revealed by new genomic study

Between 800,000 and 900,000 years ago, the population of human ancestors crashed, according to a new genomic model by Wangjie Hu and colleagues.

31 Aug 2023

Boosters slow antibody waning but hit a ceiling: Long-term COVID study reveals limits of immunity

The study tracks the long-term kinetics of antibody responses to SARS-CoV-2 after vaccination and infections in New York healthcare workers from 2020 to 2023. It reveals that antibody waning is slower after booster shots, but there's an upper limit to antibody levels, which gradually lowers with repeated SARS-CoV-2 exposures and vaccinations.

31 Aug 2023

Largest genetic study of epilepsy finds new risk genes

The largest genetic study of its kind, coordinated by the International League Against Epilepsy, including scientists from FutureNeuro at RCSI University of Medicine and Health Sciences, has discovered specific changes in our DNA that increase the risk of developing epilepsy.

31 Aug 2023

Life Science News

Scientists develop new technique to study sugars on immune cells

Gut feeling: How your microbiome could be shaping your mental health

Rotating shoulders and extending elbows may have evolved as a natural braking system for primates

Illumina's board appoints Jacob Thaysen, Ph.D. as its new Chief Executive Officer

Mutational changes in Avian flu virus could increase risk of transmission to humans

NGS-based screening identifies rare and novel thalassemia mutations in Ganzhou, China

New blood test pinpoints Parkinson's disease through mitochondrial DNA damage

Silencing two genes can make cancer cells receptive to chemotherapy

Some communities express mistrust and cynicism in response to conversations about genomics

Innovate UK funding to support the development of powdered gene therapy for bone graft augmentation

Study sheds light on immune cells' ability to collectively migrate through complex environments

Explosive Hazard Identification in Pharmaceutical Process Development

Amgen presents late-breaking Phase 2 olpasiran data at ESC 2023

Amgen to discuss application for LUMAKRAS® (sotorasib) for the treatment of KRAS G12C-positive NSCLC at FDA advisory committee meeting

Ancient population bottleneck revealed by new genomic study

Boosters slow antibody waning but hit a ceiling: Long-term COVID study reveals limits of immunity

Largest genetic study of epilepsy finds new risk genes

Scientists discover new microglial population important for memory and learning

The Clinical Importance of Circulating Tumor DNA

Laboratory instrument manufacturer Knauer is now EN ISO 13485 certified

Latest eBooks

Industry Focus eBook - Immunology (4th edition)

Industry Focus eBook - Fluorescence (1st edition)

Advances in cardiometabolic research and clinical trial design

Industry Focus eBook - Oncology (3rd edition)

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation